PA
INFU icon

PharVision Advisers’s InfuSystem Holdings INFU Stock Holding History

PharVision Advisers’s Portfolio INFU Stock Details INFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,916
Closed -$421K – 365
2025
Q4 		$421K Buy
+46,916
New +$449K 0.21% 99

Other funds holding INFU

MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PharVision Advisers's INFU Position: Q1 2026 in Review

PharVision Advisers sold out of InfuSystem Holdings (INFU) in Q1 2026, closing a stake of 46,916 shares — an estimated $421K sold.

PharVision Advisers first reported a position in INFU in Q4 2025 and held it in 1 quarter. The position peaked at $421K in Q4 2025. 96 funds tracked by Wall St. Rank hold INFU as of Q1 2026.

  • PharVision Advisers reported no remaining InfuSystem Holdings position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 46,916 InfuSystem Holdings shares in Q1 2026, an estimated $421K.
  • PharVision Advisers first reported a position in InfuSystem Holdings in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's InfuSystem Holdings position peaked at $421K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.